Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission

Nature

Volumn 402, Issue 6758, 1999, Pages 181-184

  Hein, Lutz ^a   Altman, John D ^b   Kobilka, Brian K ^b,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; NORADRENALIN; ADRENERGIC RECEPTOR ALPHA(2C); ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; QUINOXALINE DERIVATIVE; RECEPTOR, ADRENERGIC, ALPHA 2A; RECEPTOR, ADRENERGIC, ALPHA-2A;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ARTICLE; BRAIN VENTRICLE; HEART HEMODYNAMICS; KNOCKOUT MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; REGULATORY MECHANISM; ADRENERGIC SYSTEM; ANIMAL; BLOOD; BRAIN CORTEX; CROSS BREEDING; GENE DELETION; GENETICS; HEART ATRIUM; HEART MUSCLE; HEMODYNAMICS; METABOLISM; MOUSE; NERVE CELL INHIBITION; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALIA;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CEREBRAL CORTEX; CROSSES, GENETIC; GENE DELETION; HEART ATRIA; HEMODYNAMIC PROCESSES; MICE; MYOCARDIUM; NEURAL INHIBITION; NOREPINEPHRINE; QUINOXALINES; RECEPTORS, ADRENERGIC, ALPHA-2; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION;

EID: 0033547241     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/46040     Document Type: Article

References (30)

1. Taylor, A. A. Autonomic control of cardiovascular function: clinical evaluation in health and disease. J. Clin. Pharmacol. 34, 363-374 (1994).
2. Miller, R. J. Presynaptic recetors. Annu. Rev. Pharmacol. Toxicol. 38, 201-227 (1998).
3. Langer, S. Z. 25 years since the discovery of presynaptic recetors: present knowledge and future perspectives. Trends Pharmacol. Sci. 18, 95-99 (1997).
4. Starke, K., Göthert, M. & Kilbinger, H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev. 69, 864-989 (1989).
5. Stjärne, L. Basic mechanisms and local modulation of nerve impulse-induced secretion of neurotransmitters from individual sympathetic nerve varicosities. Rev. Physiol. Biochem. Pharmacol. 112, 4-137 (1989).
6. Bylund, D. B. et al. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46, 121-136 (1994).
7. 2C-adrenoceptar homolog. Molec. Pharmacol. 48, 48-55 (1995).
8. 2-adrenergic receptor subtypes b and c. Science 273, 803-805 (1996).
9. 2A-adrenergic receptor subtype. Science 273, 801-803 (1996).
10. 2-adrenoceptor agonist. Molec. Pharmacol. 51, 36-46 (1997).
11. 2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice. J. Neurosci. 18, 3035-3042 (1998).
12. 2A-adrenergic receptor knockout mice. Molec. Pharmacol. 56, 154-161 (1999).
13. Singer, E. A. Transmitter release from brain slices elicited by single pulses: a powerful method to study presynaptic mechanisms. Trends Pharmacol. Sci. 9, 274-276 (1988).
14. 2D subtype. Naunyn-Schmiedeberg's Arch. Pharmacol. 354, 253-261 (1996).
15. 2A in the rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol. 348, 35-45 (1993).
16. 2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra. Naunyn-Schmiedeberg's Arch. Pharmacol. 356, 721-737 (1997).
17. 2-autoreceptors in the rabbit pulmonary artery and human saphenous vein. Naunyn-Schmiedeberg's Arch. Pharmacol. 352, 483-490 (1995).
18. 2-adrenoceptor mediating prejunctional inhibition of cardioacceleration in the pithed rat heart. Br. J. Pharmacol. 115, 316-320 (1995).
19. 2-C10 homolog responsible for an interspecies variation in antagonist binding. Molec. Pharmacol. 42, 16-27 (1992).
20. McLachlan, E. M., Davies, P. J., Habler, H. J. & Jamieson, J. On-going and reflex synaptic events in rat superior cervical ganglion cells. J. Physiol (Lond.) 501, 165-181 (1997).
21. 2A-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc. Natl Acad. Sci. USA 94, 9950-9955 (1997).
22. Packer, M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J. Am. Coll. Cardiol. 20, 246-254 (1992).
23. Cohn, J. N. et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311, 819-823 (1984).
24. Lechat, P. et al. Clinical effects of β-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 98, 1184-1191 (1998).
25. Hein, L., Barsh, G. S., Pratt, R. E., Dzau, V. J. & Kobilka, B. K. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377, 744-747 (1995).
26. 2D-autoreceptors in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 352, 43-48 (1995).
27. Taube, H. D., Starke, K. & Borowski, E. Presynaptic receptor systems on the noradrenergic neurones of rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 299, 123-141 (1977).
28. Graefe, K. H. et al. 1,1′-Diisopropyl-2,4′-cyanine (disprocynium24), a potent uptake2 blocker, inhibits the renal excretion of catecholamines. Naunyn-Schmiedeberg's Arch. Pharmacol. 356, 115-125 (1997).
29. 1 adrenergic receptor transgenic mice. Proc. Natl Acad. Sci. USA 96, 7059-7064 (1999).
30. 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc. Natl Acad. Sci. USA 94, 6391-6396 (1997).